🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The objective of the study is to test the efficacy, safety and tolerability...
Status
Completed
Location
1218.6.3302A Boehringer Ingelheim Investigational Site
Start Date
2006-04
Trial ID
NCT00309608
Treatments Being Tested
The study objective is to demonstrate the superiority and safety of the com...
Status
Unknown
Location
The Catholic University of Korea Seoul St. Mary's Hospital
Start Date
2014-06
Trial ID
NCT02089126
Treatments Being Tested
The aim of the study is to investigate the longterm impact on cardiovascula...
Status
Completed
Location
North Alabama Research Center, LLC
Start Date
2010-11-11
Trial ID
NCT01243424
Treatments Being Tested
This is a non-inferiority study comparing omarigliptin with sitagliptin in ...
Status
Completed
Location
Multiple Locations
Start Date
2013-06-13
Trial ID
NCT01841697
The purpose of this study is to determine the safety and efficacy of albigl...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-02
Trial ID
NCT00839527
The purpose of this study is to assess the efficacy and safety of sitaglipt...
Status
Terminated
Location
Multiple Locations
Start Date
2012-10-10
Trial ID
NCT01678820
The purpose of this study is to determine if albiglutide is safe and effect...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-02
Trial ID
NCT00838903
This trial will assess the safety and efficacy of omarigliptin (MK-3102) co...
Status
Completed
Location
Multiple Locations
Start Date
2012-09-10
Trial ID
NCT01682759
Treatments Being Tested
This study will assess the effect of sitagliptin/metformin FDC 50/1000 mg (...
Status
Completed
Location
Multiple Locations
Start Date
2010-05-04
Trial ID
NCT00993187
This trial is conducted in Asia. The trial is designed to compare the effec...
Status
Completed
Location
Novo Nordisk Investigational Site
Start Date
2008-01
Trial ID
NCT00614120
Treatments Being Tested